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Abstract. Anticoagulation therapy with Warfarin is used for specific cardiovascular 
diseases to control the ability of blood clotting. Traditional ways of self-management 
therapy are based on paper forms and procedures. This paper presents an evaluation 
of the smartphone application Warfarin Guide, a computer-assisted decision-support 
system used to help patients in their management of anticoagulation therapy related 
to International Normalized Ratio (INR) values. The evaluation consisted of a 
usability test with 4 participants and a field test with 14 participants who used the 
application at home during four months. A mixed methods research approach 
included quantitative and qualitative analysis of the test results. The results showed 
that participants evaluated the Warfarin Guide as ‘useful’ for self-management of 
anticoagulation therapy, reporting key issues for further improvement. 
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1. Introduction 
Patients with specific cardiovascular diseases, e.g., mechanical heart valves, venous 
thromboembolic disorders and selected high risk patients with atrial fibrillation, are 
prescribed life-long anticoagulation therapy with Warfarin to prevent thromboembolic 
complications. The intensity of the anticoagulant therapy is monitored by measurements 
of the International Normalized Ratio (INR) value [1]. A high value of INR indicates an 
increased risk of bleeding and a low value indicates a risk of increased blood clotting. 
The latter can lead to life-threatening conditions such as pulmonary embolism or cerebral 
infarction. Food intake with vitamin K-rich vegetables, alcohol consumption, physical 
exercise, illness and stress may also influence the INR values. Patients treated with 
Warfarin may, in some cases, self-monitor the INR values by a portable coagulometer 
device that samples whole blood obtained by a fingerprick. Previous studies have 
reported fluctuations outside the therapeutic INR range [2], which brings to light 
challenges, particularly for recently diagnosed patients, regarding regular checks of their 
INR values and decision-making about dose adjustments based on the measured values.  
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In this context, the project Smartphone Warfarin Guide aims to develop an easy-
to-use application for computer-assisted anticoagulation therapy, based on an 
algorithm developed from the Norwegian national clinical guidelines for Warfarin 
therapy [3]. The project was divided into three phases: 1) user-centred design process 
[4], 2) usability tests during iterative development and 3) a randomised control trial. 
This work presents the results of the second phase. The research questions (RQs) 
stated for this study were:  
RQ1: How can a smartphone application support the self-management of 
anticoagulation therapy with Warfarin?  
RQ2: What are the benefits and constraints of using a smartphone application for 
decision-making in an anticoagulation therapy with Warfarin? 
2. Methodology 
A mixed methods research approach [5][6] was used in the evaluation of the smartphone 
application. The evaluation was conducted in two phases: 1) usability tests in a controlled 
environment (laboratory) and 2) a field test where participants continuously used the 
smartphone application during four months at home. 
In phase 1, the usability evaluation was made in the Usability Laboratory of the 
University of Agder, Norway, with 4 participants using the anticoagulation therapy. Two 
test sessions were undertaken in October and two in November of 2016. In between, 
there was an iteration in the smartphone application development. The test participants 
were recruited from the local hospital, where they had taken a course in self-management 
of INR-measurements and dosage of Warfarin. The recommended INR range for all the 
participants was 2.5 to 3.5 and they used 2 to 4 Warfarin pills daily. They were aged 
from 34 to 63 (with a mean of 53 years) and were three males and one female. 
Participants had used anticoagulation therapy for 1.5 to 6.5 years (average of 4.3 years) 
and measured INR at home 1 to 4 times each month, with the average of 2.3 times each 
month. All were smartphone users: one iPhone user and three Android users. Participants 
had several ways of self-managing INR measurement and dosage. One participant had a 
traditional paper form manually filled-in, another participant used a table with data 
printed out before appointment, another participant used the notes function in the 
smartphone and other did not write or register any data, but stated that the last 
measurements would be visible in the INR measurement device. 
The usability evaluations started with a pre-test interview that had an average 
duration of 9 minutes, to collect demographic information and participants were 
informed about the test procedure. The test sessions were led by the same moderator, and 
had an average duration of 48 minutes. The goal of the test sessions was to solve 
differentiated tasks and explore the user interface of the smartphone application in a 
Samsung smartphone device. A concurrent Think aloud protocol was employed [7][8]. 
The Usability Laboratory consisted of two rooms; one test room and one control- 
and observation room, connected through a one-way mirror with visualisation towards 
the test room, more details were presented previously [9]. Two cameras recorded the test 
sessions, one remotely controlled fixed on the wall and one document camera focusing 
on the smartphone’s user interface on a stand. The research group, with a multi-
disciplinary background within health informatics, usability engineering and medicine, 
followed the evaluation in real-time through four monitors in the control and observation 
room and made annotations. In addition, one of the developers was present during the 
usability evaluations to assist in case of technical errors. 
In phase 2, the field test was run with 14 anticoagulation therapy patients recruited 
from a local hospital. Participants used the smartphone application at home during four 
months, starting in February 2017. After month two, they filled in two questionnaires, 
the System Usability Scale (SUS) questionnaire [10] on user experience and another 
questionnaire on design and functionality of the system. After month four, there was a 
user meeting organized at the local hospital, where patients gave feedback about their 
user experience with the smartphone application. The smartphone application was used 
in conjunction with the paper-based clinical guidelines, to identify discrepancies.  
The data collection consisted of audio-visual recordings from the usability 
evaluation and interviews in the laboratory, questionnaire data and annotations from the 
tests and feedback sessions. The Norwegian Centre for Research Data approved the study, 
with project number 50277 [11]. The participation in the study was voluntary and the 
informants received written information about the project and signed a consent form. 
3. Results 
3.1. Phase 1: Usability Evaluation 
The participants needed minor assistance to install the application from the file hosting 
service Dropbox to the smartphone. The test started with the input of the result from the 
last INR measurement in a scroll down menu (Fig. 1a). The application provided then a 
recommendation of dosage for the next days and date for a new INR measurement (Fig. 
1b). Manual changes of dosage were allowed. One of the participants expressed that 
his/her INR routines were stable during normal daily conditions, but during travelling or 
in the case of sickness, there were more irregular results of the INR measurements. 
Consequently, the participant reported the flexibility to change the dose and frequency 
of measurements as desired. The participants explored the functions available; settings 
for reminder of daily dosage and weekly INR measurement, historical line diagram (Fig. 
1c), circle diagram for time in therapeutic range (Fig. 1d) and the Help and information 
function (Fig 1e). The participants were asked to activate an alarm at the same time, daily, 
for reminder of pills and weekly measurement. In the historical diagram (Fig. 1c), the 
view had limited information since the app was just installed, but one participant stated 
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Figure 1. a) Input of INR value, b) Start screen with last INR measurement and recommended dose of Warfarin, 
c) Historic diagram with overview of INR results, d) time in therapeutic range, e) Help and Information view. 
that that was the best part of the application, compared to the paper based registration 
form. The circle diagram for time in therapeutic range (Fig. 1d), shows a historic 
presentation of time below, over and in the therapeutic range visualized by a green, 
yellow or red area, which was evaluated as a useful and clear presentation. The help and 
information function (Fig 1e) had 8 choices for information on how to use the application, 
symptoms and recommendations. The medical information was taken from the national 
clinical guidelines, to which participants were acquainted. One participant stated that it 
would be practical to always have access to the guidelines through the mobile device 
instead on written on papers. In the first two evaluations, participants stated that a ‘note’ 
function would be useful for creating own notes about food, newly added medication, 
etc. The notes function was implemented in an iteration and tested in the last two 
evaluations with positive response, but one of the participants suggested that the date 
should be registered automatically in a note.  
The participants were asked about storage and data privacy. They explained that 
they would rely on the hospital to take care of security in an adequate way and found it 
useful that the hospital could access measurements, but they did not expect direct 
feedback on measurements. They expected the stored results to be used in outpatient 
ward consultations, without the need of bringing paper-based information in the future. 
Overall, the participants found the application useful for self-management of INR 
measurement and calculation of dosage. They agreed to test the application for a longer 
period of time at home. Only one of the participants found the application use complex, 
leading to some extra actions. Another participant stressed the importance of quick and 
easy daily interactions with the application, to strengthen the patient adherence to the 
application. A few errors occurred during the evaluations. There were server connectivity 
problems which were solved with manual work arounds. Participants closed several 
times the application by mistake, looking for a back function. That functionality was 
implemented in the iteration. 
3.2. Phase 2: Field Test 
Two questionnaires were sent by post mail to 14 anticoagulation therapy patients and out 
of them 13 responses were received, i.e., 93% response rate. The results of the System 
Usability Scale [10] were calculated and evaluated based on recommendations in Bangor 
et al. [12] where values in the range 70-100 indicates acceptable result (green colour), 
50-70 marginal (yellow) and below 50 is not acceptable (red), see Table 1. The mean of 
the scores is 85.0, which is placed in the middle of the acceptable result range. 
 Table 1. Results of System Usability Scale Questionnaire 
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 Mean 
100 100 80 97,5 100 57,5 77,5 72,5 100 65 72,5 100 82,5 85,0 
P= participant. 
The design suggestions in the other questionnaire referred to adaption for all 
smartphones and a missing function for manual change of a measurement’s day, as by 
default, the day for application installation was chosen. Also, export of data to a personal 
computer was suggested for redundancy, in case of a lost phone. Two discrepancies were 
found in the recommended week dose compared to the paper-based clinical guidelines.  
4. Discussion 
This paper has presented an evaluation of the Smartphone Warfarin Guide application, 
developed with a user-centred design approach. Regarding RQ1, the results showed that 
a smartphone application may support self-management of an anticoagulation therapy, 
even though there was room for improvements. Regarding benefits and constraints 
(RQ2), the application strengthens the patient empowerment by providing flexibility and 
decision-support, but the application needs to be further tested and validated according 
to regulations for medical software. Participants expressed that they hoped to able to use 
the system after the trial.  
This study has some limitations, such as including a reduced number of test 
participants. Nevertheless, the study had participants that were patients using 
anticoagulation therapy and with a background that meaningfully represented the user 
group and other studies have showed that a low number of participant can identify major 
usability issues [13]. Future work would include implementation of Bluetooth 
transmission from the measurements’ device to the smartphone application to reduce 
errors in manual input of INR measurement results. Further, a randomised controlled 
trial (RCT) is proposed, with a comparison of using the smartphone application and the 
standardised paper-based decision support system. 
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